- 💡 Help center | ☎️ Contact | 🕖 Opening hours : 9:00 - 17:00 | 🤝 Create an account
The UN commission reclassifies cannabis, which is no longer considered a risky drug.
What is CBD? Zoom in on a cannabinoid like no other
December 10, 2020
"The United Nations Commission on Narcotic Drugs (CND) made a number of decisions on Wednesday, resulting in changes to the way cannabis is regulated internationally, including its reclassification out of the most dangerous category of drugs."
A decision that comes after a long wait ...
In January 2019, WHO had unveiled six WHO recommendations for theinclusion of cannabis in the United Nations drug control treaties.
While the proposals were originally due to be voted on at the March 2019 session of the NEC, many countries had requested more time to study the endorsements and define their positions.
Among the many points made by the WHO, it was specified that cannabidiol (CBD) - a non-intoxicating compound - is not subject to international controls.
CBD has played a leading role in wellness therapies in recent years, sparking a colossal industry.
Currently, over 50 countries have adopted medicinal cannabis programs, while Canada, Uruguay and 15 American states have legalized its recreational use, with Mexico and Luxembourg about to become the third and fourth countries to do so.
Some countries made a few comments after the vote.
After the vote, some countries issued statements on their positions.
Ecuador supported all WHO recommendations and urged that the production, sale and use of cannabis should have "a regulatory framework guaranteeing good practices, quality,innovation and research development".
At the same time, the USA voted to remove cannabis from Schedule IV of the Single Convention while retaining it in Schedule I, claiming that this is "consistent with science demonstrating that while safe and effective cannabis-derived therapeutics have been developed, cannabis itself continues to pose significant risks to public health and should continue to be controlled under the international drug control conventions".
Voting against, Chile argued, among other things, that "there is a direct relationship between cannabis consumption and an increased risk of suffering from depression, cognitive impairment, anxiety, psychotic symptoms, among others", while Japan stated that non-medical use of the plant "could have negative effects on health and society, especially among young people".
Source :
Article translated from the un publication: https: //news.un.org/en/story/2020/12/1079132
